• About Us
    • Overview
    • Senior Team
    • Board of Non-Executive Directors
    • Investors & Shareholders
  • Our Technology
  • Pipeline
  • NephroScan®
  • News & Events
    • Press Releases
    • In the News
    • Events
    • Publications
  • Careers
  • Contact
  • Menu Menu

In The News

Labiotech – Future of cancer treatment: what will therapy look like in 2034?

5 February 2024

View article

https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg 0 0 futurum https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg futurum2024-02-05 16:06:402024-02-06 16:08:49Labiotech – Future of cancer treatment: what will therapy look like in 2034?

Biocentury – Series A companies: the class of 2023

3 February 2024

View article

https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg 0 0 futurum https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg futurum2024-02-03 16:01:202024-02-06 16:09:24Biocentury – Series A companies: the class of 2023

Endpoints – Lutetium, actinium or lead: Can isotope type offer an edge in radiotherapy?

19 January 2024

View article

https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg 0 0 futurum https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg futurum2024-01-19 14:40:592024-01-19 14:40:59Endpoints – Lutetium, actinium or lead: Can isotope type offer an edge in radiotherapy?

Drug Discovery World – Podcast: Developing novel targeted radiopharmaceuticals for cancer treatment

4 January 2024

Listen here

https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg 0 0 futurum https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg futurum2024-01-04 11:59:142024-01-15 11:59:49Drug Discovery World – Podcast: Developing novel targeted radiopharmaceuticals for cancer treatment

Pharmaphorum – ADCs shine at ESMO ’23, as pharma makes case for early immunotherapy interventions

14 November 2023

View article

https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg 0 0 futurum https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg futurum2023-11-14 15:35:422023-11-15 15:36:50Pharmaphorum – ADCs shine at ESMO ’23, as pharma makes case for early immunotherapy interventions

Drug Discovery World – Meet the Researcher: Germo Gericke

19 July 2023

Download PDF

View article (behind a paywall)

https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg 0 0 futurum https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg futurum2023-07-19 15:02:452023-08-02 12:03:39Drug Discovery World – Meet the Researcher: Germo Gericke

HealthCapital – Portrait – Targeted Finding and Eliminating Cancer Cells

11 July 2023

View article

https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg 0 0 futurum https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg futurum2023-07-11 11:57:352023-08-02 11:59:52HealthCapital – Portrait – Targeted Finding and Eliminating Cancer Cells

MedNous – Interview: Setting the pace in radiopharmaceutical development

26 May 2023

Download PDF

https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg 0 0 futurum https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg futurum2023-05-26 13:11:142023-05-29 13:14:36MedNous – Interview: Setting the pace in radiopharmaceutical development

Spotlight On: Radiopharmaceuticals upstart Ariceum Therapeutics | FirstWord Pharma +

16 May 2023

Download PDF

https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg 0 0 futurum https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg futurum2023-05-16 10:06:242023-05-23 10:07:38Spotlight On: Radiopharmaceuticals upstart Ariceum Therapeutics | FirstWord Pharma +

tagesspiegel.de – 48 Millionen Euro für Start-up Im Kampf gegen Lungenkrebs

4 May 2023

Download PDF

https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg 0 0 futurum https://ariceum-therapeutics.com/wp-content/uploads/2022/04/Ariceum_Logo_Web_290px.svg futurum2023-05-04 10:05:152023-05-23 10:08:48tagesspiegel.de – 48 Millionen Euro für Start-up Im Kampf gegen Lungenkrebs
Page 2 of 3123

© Ariceum Therapeutics

Website by FisherPaul

  • Imprint
  • Privacy Policy

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settings

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visit to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Other cookies

The following cookies are also needed - You can choose if you want to allow them:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.